US based Propeller Health, provider of a digital health solution for improving outcomes in asthma and chronic obstructive pulmonary disease (COPD), will be collaborating with GSK to develop a new sensor for GSK’s ElliptaTM inhaler for use in certain clinical studies in asthma and COPD.
40 potential new medicines and vaccines offer significant opportunity to drive long-term performance and deliver new benefits to patients and consumers.
GSK Singapore was awarded the Institution of Chemical Engineers’ (IChemE) top honour for Process Safety at its recent 2015 IChemE Singapore Awards.
GSK CEO Sir Andrew Witty says a strong presence in Asia is vital to the future growth of the company
Singapore is hugely important to GSK, as it is the regional HQ for our Emerging Markets and Asia Pacific pharmaceuticals and consumer healthcare business and GSK makes a significant contribution to Singapore’s biomedical science industry.
Debjit Rudra joins as General Manager for the South East Asia area and member of the Asia Middle East Africa leadership team.
by Fortune magazine